1. Home
  2. NAVI vs PHAR Comparison

NAVI vs PHAR Comparison

Compare NAVI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navient Corporation

NAVI

Navient Corporation

HOLD

Current Price

$9.13

Market Cap

760.4M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$10.41

Market Cap

793.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAVI
PHAR
Founded
1973
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
760.4M
793.4M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
NAVI
PHAR
Price
$9.13
$10.41
Analyst Decision
Sell
Strong Buy
Analyst Count
6
3
Target Price
$10.00
★ $38.33
AVG Volume (30 Days)
★ 1.2M
27.6K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
★ 6.73%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.44
N/A
Revenue
★ $271,000,000.00
N/A
Revenue This Year
$76.23
$10.04
Revenue Next Year
$15.73
$2.51
P/E Ratio
★ $21.14
$3,041.22
Revenue Growth
N/A
★ N/A
52 Week Low
$7.33
$9.62
52 Week High
$13.50
$21.34

Technical Indicators

Market Signals
Indicator
NAVI
PHAR
Relative Strength Index (RSI) 46.29 40.15
Support Level $7.91 $9.62
Resistance Level $9.74 $13.51
Average True Range (ATR) 0.34 0.48
MACD -0.07 -0.02
Stochastic Oscillator 19.09 10.39

Price Performance

Historical Comparison
NAVI
PHAR

About NAVI Navient Corporation

Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in two segments: Federal Education Loans, and Consumer Lending. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: